Cost-Utility of Omalizumab Compared With Standard of Care for The Treatment of Chronic Spontaneous Urticaria (Csu)
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.571
https://www.valueinhealthjournal.com/article/S1098-3015(15)02647-9/fulltext
Title :
Cost-Utility of Omalizumab Compared With Standard of Care for The Treatment of Chronic Spontaneous Urticaria (Csu)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02647-9&doi=10.1016/j.jval.2015.09.571
First page :
A423
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
489